ulipristal acetate has been researched along with Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, YJ; Choi, JJ; Choi, JY; Hwang, JR; Kim, HS; Lee, JW; Ryu, JY; Sa, JK | 1 |
1 other study(ies) available for ulipristal acetate and Sarcoma
| Article | Year |
|---|---|
Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
Topics: Animals; Cell Death; Chemokine CCL2; DNA, Complementary; Female; Humans; Leiomyoma; Mice; Receptors, Progesterone; Sarcoma; Signal Transduction; STAT3 Transcription Factor; Uterine Neoplasms | 2023 |